2023年3月21日

星期二,2023年3月7日就伊鲁宾是被任命为新椅子的澳大利亚业务增长基金(ABGF)。ABGF增长型资本澳大利亚中小企业通过提供了一个独特的公私合作投资模式旨在填补差距后期风险投资和更大的收购基金。该基金成立的初始资本5.4亿美元联邦政府之间的合作和六大银行在澳大利亚。伊莱娜·鲁宾是一个德高望重的椅子和非执行董事在各种行业的丰富经验,包括养老、投资、专业服务、技术、电信、保险、政府和金融服务。她过去和现在NED角色跨不同行业,包括上市公司和非上市公司如Dexus,澳洲电信,斯莱特和戈登。她目前正在椅子上的维多利亚时代的保险机构和管理也过去AustralianSuper主席和Afterpay。伊莱的热情让不同的人在一起成长的企业有一个积极的影响他们运营的社区ABGF让她完美的候选人。她吸引ABGF独特的公私合作模式和它的目的来支持中小企业行业的创新和创业精神。伊莱认为“为这些企业提供资本增长是至关重要的支持创新,技术,和技能。”Anthony Healy, CEO and Managing Director of ABGF, welcomed Elana as the new Board Chair, stating that "She brings extensive experience across a range of organisations, including public-private partnerships and is driven by the same values as the fund – to back ambitious businesses to help them grow and thrive." Healy also mentioned that under Mike Baird's leadership, the Fund established strong momentum, opened its offices in Sydney and Melbourne, built a diverse and experienced team, and made its first eight investments. Elana’s appointment as Chair of ABGF is significant as the fund plays a vital role in supporting SMEs to scale and in turn create jobs, economic growth and support Australian entrepreneurship. The fund's primary purpose is to connect SMEs to capital, expertise, and wider local and international networks. It takes a minority stake in the business (up to 49%) during opportune times of growth, while ensuring the original founders retain control of the business. The ABGF is building an investment pipeline of companies with potential for growth and is open to small-medium enterprise businesses with over $2 million in revenue and a proven business model. In conclusion, Elana Rubin's appointment as the Chair of the ABGF is a testament to her vast experience and expertise in various sectors. Her passion for growing businesses that have a positive impact on the communities they operate in aligns with the fund's purpose. With the ABGF's unique public-private partnership investment model, it is poised to fill the gap between late-stage venture capital and larger buyout funds and provide long-term patient growth capital for SMEs to scale and succeed. Related job moves